Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?Juthathip Mongkolsapaya, Thaneeya Duangchinda, Wanwisa Dejnirattisai, et al.
Cell Reports|February 7, 2019
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in MiceVanessa Salazar, Brett W Jagger, Juthathip Mongkolsapaya, et al.
Nature Immunology|October 17, 2018
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virusMax Renner, Aleksandra Flanagan, Wanwisa Dejnirattisai, et al.
Nature Immunology|September 4, 2019
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infectionJose Luis Slon-Campos, Wanwisa Dejnirattisai, Brett W Jagger, et al.
The Journal of Biological Chemistry|May 14, 2011
Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signalingAleksandra A Watson, Andrey A Lebedev, Benjamin A Hall, et al.
The Journal of Infectious Diseases|April 5, 2018
Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the AmericasMagelda Montoya, Matthew Collins, Wanwisa Dejnirattisai, et al.
Nature|June 25, 2016
Structural basis of potent Zika-dengue virus antibody cross-neutralizationGiovanna Barba-Spaeth, Wanwisa Dejnirattisai, Alexander Rouvinski, et al.
Nature Communications|June 3, 2026
Heterogeneity and dynamics of DENV-specific CD8 + T cells in dengue infectionSirawit Srikor, Waradon Sungnak, Chawinya Trakoolsoontorn, et al.
Nature Communications|March 29, 2024
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Daming Zhou, Piyada Supasa, Chang Liu, et al.
Pageof 8